269 related articles for article (PubMed ID: 12011460)
21. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
[TBL] [Abstract][Full Text] [Related]
22. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
23. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cells in HIV-1 infection: role of NK cell-mediated non-cytolytic mechanisms in pathogenesis of HIV-1 infection.
Kottilil S
Indian J Exp Biol; 2003 Nov; 41(11):1219-25. PubMed ID: 15332487
[TBL] [Abstract][Full Text] [Related]
25. Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
Tan DB; Fernandez S; French M; Price P
Clin Immunol; 2009 Jul; 132(1):63-70. PubMed ID: 19403337
[TBL] [Abstract][Full Text] [Related]
26. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.
Kottilil S; Chun TW; Moir S; Liu S; McLaughlin M; Hallahan CW; Maldarelli F; Corey L; Fauci AS
J Infect Dis; 2003 Apr; 187(7):1038-45. PubMed ID: 12660917
[TBL] [Abstract][Full Text] [Related]
27. Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection.
Vasan S; Poles MA; Horowitz A; Siladji EE; Markowitz M; Tsuji M
Int Immunol; 2007 Aug; 19(8):943-51. PubMed ID: 17702988
[TBL] [Abstract][Full Text] [Related]
28. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
29. Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?
Biswas P; Galli A; Galli L; Tassan Din C; Vecchi A; Malnati M; Lazzarin A; Tambussi G
Cytometry B Clin Cytom; 2007 Nov; 72(6):433-41. PubMed ID: 17474134
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
31. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
De Rossi A; Walker AS; Klein N; De Forni D; King D; Gibb DM
J Infect Dis; 2002 Aug; 186(3):312-20. PubMed ID: 12134227
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
[TBL] [Abstract][Full Text] [Related]
33. CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques.
Vieillard V; Habib RE; Brochard P; Delache B; Bovendo HF; Calvo J; Morin J; Picq I; Martinon F; Vaslin B; Le Grand R; Debré P
AIDS; 2008 Jan; 22(2):185-92. PubMed ID: 18097220
[TBL] [Abstract][Full Text] [Related]
34. Epinephrine-induced mobilization of natural killer (NK) cells and NK-like T cells in HIV-infected patients.
Sondergaard SR; Ullum H; Skinhoj P; Pedersen BK
Cell Immunol; 1999 Nov; 197(2):91-8. PubMed ID: 10607426
[TBL] [Abstract][Full Text] [Related]
35. Thalidomide suppresses Up-regulation of human immunodeficiency virus coreceptors CXCR4 and CCR5 on CD4+ T cells in humans.
Juffermans NP; Verbon A; Olszyna DP; van Deventer SJ; Speelman P; van Der Poll T
J Infect Dis; 2000 May; 181(5):1813-6. PubMed ID: 10823791
[TBL] [Abstract][Full Text] [Related]
36. IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication.
Iannello A; Boulassel MR; Samarani S; Tremblay C; Toma E; Routy JP; Ahmad A
J Leukoc Biol; 2010 May; 87(5):857-67. PubMed ID: 20103765
[TBL] [Abstract][Full Text] [Related]
37. Infection of natural killer cells by human herpesvirus 6.
Lusso P; Malnati MS; Garzino-Demo A; Crowley RW; Long EO; Gallo RC
Nature; 1993 Apr; 362(6419):458-62. PubMed ID: 7681936
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy.
Weber K; Meyer D; Grosse V; Stoll M; Schmidt RE; Heiken H
Immunobiology; 2000 Aug; 202(2):172-8. PubMed ID: 10993291
[TBL] [Abstract][Full Text] [Related]
39. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1.
Dezzutti CS; Guenthner PC; Cummins JE; Cabrera T; Marshall JH; Dillberger A; Lal RB
J Infect Dis; 2001 Apr; 183(8):1204-13. PubMed ID: 11262202
[TBL] [Abstract][Full Text] [Related]
40. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.
Lichtfuss GF; Cheng WJ; Farsakoglu Y; Paukovics G; Rajasuriar R; Velayudham P; Kramski M; Hearps AC; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
J Immunol; 2012 Aug; 189(3):1491-9. PubMed ID: 22745371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
